500 Percent Rise In Stillbirths; Birthrates Declining; Dr. Mike Yeadon Names Names

 

Leaked Hospital Memo Reveals 500 Percent Rise In Stillbirths; Fetal Specialist Explains Likely Cause

“Last week, a hospital memo was leaked to us by a nurse in Fresno (https://www.theepochtimes.com/t-fresno), California (https://www.theepochtimes.com/t-california). The note revealed how this hospital is experiencing a dramatic rise in the number of stillbirth cases. Whereas before, the hospital would see an ‘average of one to two every three months’—they were now seeing upwards of 22 stillbirths per month.

This leaked anecdote seems to align with other anecdotal evidence across the country, showing a potential rise in problems with fertility, miscarriages, and fetal development.

And so, in order to get a clearer picture of what is happening, and why, we spoke with Dr. James Thorp, a Florida-based OB-GYN who specializes in maternal-fetal medicine.”


Aborted  Fetus Cells Products in our food and drinks


Dr James Thorp: “We are talking about birth rates declining all over the world, my main concern with these babies is VAIDS; these babies do not have a normal immune system…”It’s a bloody disaster”.


Dr. Mike Yeadon Names Names: ‘You Are Responsible’ for Crimes Against Humanity

 

Pfizer admits to fraud in court; Ex Pfizer Scientist Dr. Mike Yeadon; The midterms are the current task at hand; Protect Your Brain; Law of One

Pfizer admits to fraud in court


Ex Pfizer Scientist Dr. Mike Yeadon on what the covid vaccines were designed to do and how we the people need to standup and say no. It is time for Nuremburg 2.

Pilots come forward to call out the lack of safety from the Covid vaccines.


Kash was asked about Trump saying, “we caught them all,” and when that information will be released.  Kash answered with, “in Trump time.” He explained the importance of leadership changes within the agencies & departments that run the government.  The midterms are the current task at hand, so go vote!

HEALTH

Protect Your Brain With These Natural Substances

Several plant compounds have been shown to prevent or treat neurological decline
BY GREENMEDINFO TIMEJUNE 14, 2022

Your brain is command central for nearly all your body’s normal waking functions.

It’s the most complex organ in the human body, possessing around 100 billion neurons (nerve cells) and more than 100,000 miles of blood vessels. It’s responsible for controlling such functions as walking, talking, thinking, and breathing. Therefore, protecting the brain is a matter of life and breath.

A healthy brain is crucial at any age, but it is particularly important to safeguard when the brain is still forming (up to age 25) and in older adults. If you’re having lapses in memory and attribute it to “senior moments,” the signs of mild cognitive decline (MCD) may already be in effect.

But don’t worry—numerous studies have linked specific natural substances to delaying and even reversing MCD. Read on and learn how to protect your all-important brain with these six naturally neuroprotective substances.

Curcumin

The natural plant compound responsible for turmeric’s bright orange color, curcumin is a powerful antioxidant linked to dozens of beneficial health effects. One purported benefit that has been extensively researched is curcumin’s ability to protect the aging brain, an important effect at any age, especially when symptoms of dementia are present.

A 2012 study published in Ayu on the effects of turmeric on Alzheimer’s disease patients with severe behavioral and psychological symptoms of dementia showed that patients “improved remarkably” as a result of consuming 100 milligrams (mg) of curcumin daily for 12 weeks.

Symptoms such as agitation, anxiety, apathy, and urinary incontinence began improving after patients were prescribed turmeric powder capsules, without any adverse reactions noted. After three months of treatment, neuropsychiatric scores showed that symptoms were less acute and the burden on caregivers had lessened. After one year on the turmeric supplement, patients had not experienced a return of prior symptoms of dementia.

Ginsenosides

While you may not be familiar with their name, ginsenosides are potent plant compounds that have been isolated from a plant called Panax, which is widely known for its healthy roots—ginseng. Responsible for the pharmacological effects of ginseng, ginsenosides play a critical role in the body’s inflammatory and disease responses and are featured in a deepening catalog of research that may help prevent and treat inflammatory diseases, including those affecting the brain.

A recent study published in Frontiers in Pharmacology explored the effects of ginsenosides and their probable neuroprotective mechanisms in ischemic strokes, the most common type of stroke. These strokes occur when a blood vessel leading to the brain is obstructed.

After an exhaustive meta-analysis evaluating the effects of ginsenoside-Rb1, researchers concluded that ginsenosides have a potential neuroprotective effect that works through an array of mechanisms, including attenuating brain water content, promoting neurogenesis, reducing cell death, and providing antioxidative, anti-inflammatory effects. G-Rb1 also supplemented energy and enhanced cerebral circulation.

Ginkgo Biloba

Ginkgo biloba has a long history as a natural health aid, with anecdotes describing its use for asthma and bronchitis as far back as 2600 BCE. Most ginkgo biloba supplements are made from the leaves of the ginkgo tree, one of the longest-lived tree species on the planet, dating back more than 200 million years. A single ginkgo tree can live for as long as 1,000 years, so is it any wonder these trees may help improve your memory?

A 2015 meta-analysis published in the Journal of Pharmaceutical Health Care and Sciences looked at the efficacy and safety of ginkgo biloba extract for the treatment of dementia. It found that taking a 240-mg daily dose of ginkgo biloba extract is effective and safe in the treatment of patients with Alzheimer’s disease complicated by dementia, as well as vascular and mild forms of dementia.

A human trial on healthy, active young men found that six weeks’ supplementation with ginkgo biloba provided a boost in athletic performance, endurance, and antioxidant capacity. The study, published in Archives of Medical Science in 2015, found ginko also elicited better neuroprotection through increased exercise-induced production of brain-derived neurotrophic factor, a biomarker that serves to modulate brain activity and plays a part in neuroplasticity, the ability of the brain to regenerate in a healthy manner.

Resveratrol

Like curcumin, resveratrol is a natural plant polyphenol responsible for the deep color of wine, grapes, and red and blue berries. Known to pack an antioxidant punch, resveratrol has been synthesized into supplement form with promises to remedy everything from overweight to heart disease. But what does science say about this trendy panacea when it comes to brain health?

2017 Australian study tested whether chronic supplementation with resveratrol could improve brain function, cognition, and mood in post-menopausal women. Eighty women aged 45 to 85 years were randomized to receive resveratrol or placebo for 14 weeks. Effects on cognitive performance, cerebral blood flow, and arterial stiffness in the middle cerebral artery were measured.

Cerebrovascular responsiveness (CVR) to both cognitive testing and hypercapnia (excessive carbon dioxide in the blood) were also assessed, and mood questionnaires were administered. Compared to placebo, resveratrol elicited 17 percent increases in CVR to both hypercapnic and cognitive stimuli. Performance on cognitive tasks for verbal memory significantly improved, as did overall cognitive performance.

Mood also improved in multiple measures, indicating that regular consumption of a modest dose of resveratrol may enhance both cerebrovascular function and cognition. Researchers posited that resveratrol supplementation could potentially reduce the heightened risk of accelerated cognitive decline in post-menopausal women and offers a promising therapeutic treatment for this population group.

Melatonin

Melatonin has garnered fame as a natural sleep-aid, but did you know that it also protects the brain? A naturally occurring hormone that helps regulate the sleep-wake cycle, melatonin is a neuroprotective agent that may hold therapeutic promise for brain disorders such as Alzheimer’s, Parkinson’s, and stroke.

Secreted by the pineal gland in the brain, melatonin can also be taken as a supplement. Supplementation has been shown to reduce the incidence of delirium in older adults. A 2018 meta-analysis of both human and animal studies provided clinical evidence that melatonin treatment after traumatic brain injury (TBI) can significantly improve both pathological and behavioral outcomes in TBI patients. Observed results, published in BMC Geriatrics include reduced size of contusions and cerebral edema, and enhanced cognition.

The journal Neural Regeneration Research published a 2021 animal study on the effects of melatonin on rats with induced Alzheimer’s disease. Rats were administered 30 mg of melatonin per kilogram (kg) of body weight for 13 consecutive days.

Melatonin supplementation ameliorated learning and memory impairments on maze tests, improved the morphology and density of microvessels in the brain, alleviated pathological injuries of cerebral neurons, and decreased the expression of vascular endothelial growth factor and its receptors. Researchers concluded that melatonin supplementation can improve the cognitive function of patients with Alzheimer’s disease.

Cannabidiol

Cannabidiol, or CBD as it’s commonly known, is an isolated active compound in the cannabis plant that has been shown to effectively treat insomnia, pain, and brain disorders such as anxiety and epilepsy. Despite demonstrating such powerful effects on the brain, CBD is non-psychoactive, meaning it won’t get you high. But according to the latest medical science, it may possess strong neuroprotective properties to support your brain as you age.

Studies on CBD as an adjunct treatment for Parkinson’s disease patients have yielded promising results. Published in the Journal of Psychopharmacologya 2009 study tested six Parkinson’s patients and found that doses of CBD ranging from 150 mg to 400 mg over four weeks produced significant improvements in psychosis episodes and symptoms.

In 2014, researchers conducted a double-blind trial with a group of 21 Parkinson’s patients receiving either CBD at 75 mg/day, 300 mg/day, or placebo for six weeks. Increases in well-being and quality of life were observed in the 300 mg/day group versus the placebo group. Researchers hypothesized that these improvements may have been due to cannabidiol’s “anxiolytic,” “antidepressant,” “anti-psychotic,” and “sedative” properties.

CBD isn’t the only active plant compound in the cannabis plant (collectively called “cannabinoids”) that is proving its value to medical researchers. THC, the cannabinoid that conveys marijuana’s psychoactive properties, has been found to be superior to prescribed drugs in the treatment of Alzheimer’s disease. In their findings, published in Molecular Pharmaceutics, researchers attribute this compelling discovery to a “previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.”

The GMI Research Group is dedicated to investigating the most important health and environmental issues of the day. Special emphasis will be placed on environmental health. Our focused and deep research will explore the many ways in which the present condition of the human body directly reflects the true state of the ambient environment. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Sign up for the newsletter at www.GreenmedInfo.health

 

Former Pfizer VP: ‘No need for vaccines,’ ‘the pandemic is effectively over’

Dr. Mike Yeadon, Pfizer’s former Vice President and Chief Scientist for Allergy & Respiratory, states that the drive for a universal vaccine has ‘the whiff of evil’ which he ‘will oppose … vigorously.’
Mon Nov 23, 2020 – 11:09 am EST Published by  By Life Site 
Featured Image
, Pfizer’s former Vice President and Chief Scientist for Allergy & Respiratory, states that the drive for a universal vaccine has ‘the whiff of evil’ which he ‘will oppose … vigorously.’

In a recent article, Dr. Michael Yeadon, who “spent over 30 years leading new [allergy and respiratory] medicines research in some of the world’s largest pharmaceutical companies,” and retired from Pfizer with “the most senior research position in this field,” wrote:

There is absolutely no need for vaccines to extinguish the pandemic. I’ve never heard such nonsense talked about vaccines. You do not vaccinate people who aren’t at risk from a disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects.

The British national’s comments come at the end of a comprehensive criticism of the Scientific Advisor Group for Emergencies (SAGE), a government agency of the U.K. tasked with advising the central government in emergencies. SAGE has played a predominant role in determining public lockdown policies in the U.K., including those recently implemented, as a response to the COVID-19 virus.

After pointing out that SAGE lacked essential expertise in the field they are addressing, with “no clinical immunologists” as members, Yeadon highlights two fundamental errors they have made in their presuppositions which cause their overall conclusions to go radically awry leading to the “torturing [of] the population for the last seven months or so.”

First Fundamental Error: “Ridiculous” presumption of 100% susceptibility

Yeadon states this notion is “ridiculous because while SARS-CoV-2 is indeed novel, coronaviruses are not. There’s no such thing as an ‘ancestor-less virus’.” Indeed, he points out, there are at least “four, endemic, common-cold inducing coronaviruses … [which] circulate freely in UK and elsewhere.” Those who have been infected by “one or more of these endemic, common-cold producing coronaviruses in the past, have a long-lived and robust [T-cell] immunity, not only to those viruses, but to closely related viruses. SARS-CoV-2 is one such closely-related virus.”

Striking once again at the competence of SAGE, Dr. Yeadon states, “To not expect such cross-over is … to demonstrate the lack of the requisite understanding to build a model reliable enough to use.”

Further, he states, that the common PCR test which is used for detecting COVID-19 “cases,” may come out positive when someone is infected with one of these common cold coronaviruses rendering this test that much less reliable. Of course, based on the final results of these tests, many thousands of individuals have been ordered to disrupt their lives and “self-quarantine” for up to 14 days.

Finally, drawing from the scientific data, Dr. Yeadon concludes that due to previous exposure to common-cold coronaviruses, “a significant proportion (30%) of the population went into 2020 armed with T-cells capable of defending them against SARS-CoV-2, even though they had never seen the virus… SAGE was naively wrong to assume ‘everyone was susceptible’.”

Second Fundamental Error: An “amateur underestimate” of the infection rate

SAGE’s second erroneous assumption is “The belief that the percentage of the population that has been infected can be determined by surveying what fraction of the population has antibodies” developed due to infection with COVID-19.

Because of this assumption, “SAGE believes that less than 10% of the population have so far been infected by SARS-CoV-2.”

However, Yeadon clarifies that it’s “well understood that not every person, infected by a respiratory virus, goes on to produce antibodies. And many people, having prior immunity, never get properly infected anyway.”

While almost all of those with significant symptoms, who were admitted to a hospital, produce antibodies, those with “milder responses to the virus” do not “all produce antibodies.” Nevertheless, all of those infected have been shown to have “T-cells in their blood, capable of responding to SARS-CoV-2,” and thus they still develop immunity.

Drawing from two independent methods, which arrive at the same general conclusion, Yeadon demonstrates that the real infection rate is “in the mid-20s to low-30’s per cent,” and thus SAGE’s estimate of 7% “is a gross and amateur underestimate.”

Why it matters…“the pandemic is effectively over”

With a false presumption that 100% of the population is susceptible to the virus, along with only 7% having been infected, it is the view of SAGE, that “the pandemic has only just begun.” Yeadon clarifies, however, that this is “palpable nonsense.”

Since it is demonstrable that “around 30% of the population had prior immunity,” and if one includes some young children who are “resistant,” 40%, and while considering that the infection rate is “somewhere [in] the mid-20s to low-30s per cent,” this means that around 65 to 72% of the population currently has immunity to COVID-19.

And considering the reality of herd immunity, when susceptibility to a virus falls this low, at around 28 to 35%, “that population can no longer support an expanding outbreak of disease,” and thus the virus “wanes and disappears.”

Therefore, Yeadon concludes, “the pandemic is effectively over and can easily be handled by a properly functioning NHS (National Health Service). Accordingly, the country should immediately be permitted to get back to normal life.”

He further stipulates that he is “incandescent with rage at the damage” SAGE has “inflicted” on the U.K., charging that they have “either been irredeemably incompetent” or “dishonest,” and thus “they should be disbanded immediately and reconstituted,” as “they haven’t a grasp of even the basics required to build a model and because their models are often frighteningly useless.”

Concerns with Pfizer COVID-19 Vaccine: Severe complications

Despite an estimated 65 to 72% of the population now having immunity to COVID-19, a percentage which indicates a critical level of herd immunityOperation Warp Speed in the United States appears intent to follow the globalist campaign advanced by Bill Gates and vaccinate all 328 million people in the nation with the Pfizerproduct or others emerging for approved distribution in the coming months.

Notwithstanding the fact that no vaccine has ever been successfully developed for any coronavirus, and such an endeavor would normally take years to safely and adequately complete, the Food and Drug Administration (FDA) has permitted the fast-tracking of this process skipping the standard stage of testing on animals to directly test these vaccines on humans.

Immediate results from some of these trials have included “severe” complications, involving headaches, fever, body aches and symptoms similar to a “severe hangover.” Further, as the New York Times emphasizedPfizer’s initial claim that their vaccine was “more than 90 percent effective,” was “delivered in a news release, not a peer-reviewed medical journal. It is not conclusive evidence that the vaccine is safe and effective.”

Expected ‘high volume’ of adverse reactions

And given the enormous scale of the stated goal, of administering these chemicals to hundreds of millions of people, when there is normally some rate of severe complications to the use of vaccines, the negative results may be significant. For example, one study of influenza vaccines administered to adults over 65 years of age, found a rate of approximately 1% which experienced severe side effects. If a COVID-19 vaccine is merely similar for individuals in the same age bracket (54M in population), that would equate to 540,000 individuals in this age bracket alone who may need medical care in a hospital system which provides less than 925,000 total beds.

Curiously, there is evidence that at least the United Kingdom is preparing for a high number of adverse effects due to the COVID-19 vaccinations. That government’s Medicines & Healthcare products Regulatory Agency (MHRA), posted a bid request stating that “For reasons of extreme urgency,” they seek “an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs).” It goes on to explain that “it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine,” and that this “represents a direct threat to patient life and public health.”

New ‘unproven’ mRNA technology: 20% ‘serious injury rate’

Other concerns about the Pfizer vaccine is that it would be the first to use “an as-yet-unproven technology platform that relies on something called messenger RNA, usually shortened to mRNA.” Moderna, another corporation striving to develop a COVID-19 vaccine, is also venturing to utilize this mRNA platform. In May, Children’s Health Defense reported that clinical trials for Moderna’s vaccine had a 20% “serious injury rate” in its high-dose group.

Debi Vinnedge, executive director at Children of God for Life, a pro-life organization which specializes in the moral evaluation of vaccines, told LifeSiteNews, “[I]f Moderna and Pfizer are the ones supplying the first rounds of vaccines and they mandate it, that could be a disaster. They are both using brand new technology with the mRNA that has never been used in a vaccine before and they are pushing this through in a matter of months of testing, rather than the typical 4-6 years of testing.”

Mandates and Public Distrust

With a push for vaccine mandates on the rise, and resistance for such invasive measures emerging in response, a recent study indicates a growing discomfort among Americans with vaccines overall.

report from Civic Science (CS) indicates “a steady decline in the percentage of U.S. adults who say they’re ‘very’ comfortable with vaccines overall.” In fact, CS states, “the monthly percentage of those highly comfortable with vaccinations at large fell more than twenty percentage points since the start of 2020 (69% in January compared to October’s 47%).”

In addition, “only 22% percent of those surveyed say they would get the vaccine right away,” and CS concludes, “it’s clear that hesitancy to receive a future vaccine … is running rampant across the country” and this “sheds light on just how difficult it is for many to trust a future vaccine right now.”

Manipulation of the Public

Serving to counteract this trend, Yale University, in collaboration with the U.S. government, sponsored a study to determine the most effective means of persuading Americans to take the COVID-19 vaccine.

The study tests a variety of approaches, such as appeals to “Personal freedom,” “Economic benefit,” “Self-interest,” fears of “Guilt,” “Embarrassment,” and actually being a coward.

While several of the appeals are straightforward arguments, others hint at a willingness to use public shaming to elicit compliance.

One, for instance, “asks the participant to imagine the guilt they will feel if they don’t get vaccinated and spread the disease,” with variants exchanging guilt with anger or embarrassment. Another suggests someone who refuses vaccination “doesn’t understand how infections are spread or who ignores science.” Another declares that “those who choose not to get vaccinated against COVID-19 are not brave.”

The findings of this study will likely influence the messaging of state officials and academic institutions who have discussed mandating vaccination, as well as advertising campaigns surrounding a vaccine once it is completed.

Coercion of Black Communities and Children

Other strategies of coercion being developed include the “bundling” of vaccine mandates “with other safety net services,” for the poor, including “food security, rent assistance, and free clinic services” for “vulnerable populations,” with “Black and minority communities” receiving special mention.

And the District of Columbia (DC) is advancing a bill which circumvents parental consent when it comes to their minor children being given a vaccine. The “Minor Consent for Vaccinations Amendment Act of 2019,” states, “this bill permits a minor of any age to consent to receive a vaccine where the vaccination is recommended by the United States Advisory Committee on Immunization Practices. It also establishes that if a minor is able to comprehend the need for, the nature of, and any significant risks inherent in the medical care then informed consent is established.”

According to The Vaccine Reaction, “The bill would not only permit children aged 11 years and older to give consent for doctors and other vaccine administrators to give them vaccines without their parents’ knowledge or consent, but would also require insurance companies, vaccine administrators and schools to conceal from parents that the child has been vaccinated.”

The report clarifies, “If this bill passes, it is clear that minor children will be at risk of being pressured and coerced into getting a COVID-19 vaccine behind their parents’ back.”

Pfizer a “convicted serial felon”

Robert F. Kennedy, Jr., nephew of former U.S. president John F. Kennedy, environmental attorney, author, and founder of Children’s Health Defense, has been raising awareness about vaccines injuring children for decades. In addition to the organization’s firm opposition to the DC bill above, Kennedy has singled out Pfizer as one of several vaccine producers with a record of incurring criminal penalties for their products.

In a July debate, Kennedy emphasized that Pfizer, and three other leading developers of coronavirus vaccines, GlaxoSanofiMerck, are “convicted serial felon[s].”

“In the past 10 years, just in the last decade, those companies have paid 35 billion dollars in criminal penalties, damages, fines, for lying to doctors, for defrauding science, for falsifying science, for killing hundreds of thousands of Americans knowingly,” Kennedy said during the debate.

“It requires a cognitive dissonance for people who understand the criminal corporate cultures of these four companies to believe that they’re doing this in every other product that they have, but they’re not doing it with vaccines.”

Following the announcement of Pfizer’s “90 percent effective” coronavirus vaccine, with the anticipation of imminent release, the firm’s stock price rose “15 per cent from $36.40 … to $41.94 per share,” at which point the company’s CEO and Chairman, Albert Bourla, sold 61.8 per cent of his shares in the company “for almost $5.6 million.” The Independent reports that in response to inquiries Pfizer replied that this transaction was an “automated process, set up earlier this year” where “shares are sold provided they go above a pre-agreed price.”

Yeadon: Vaccine proposals have ‘the whiff of evil’

While a government, media and corporate campaign prepares to “inoculate 300 million Americans by spring of 2021,” the voice of Michael Yeadon, along with those of tens of thousands of other medical scientists and practitioners remain suppressed and unheeded.

 

“Any such proposals” of universal inoculation, Yeadon writes, “are not only completely unnecessary but if done using any kind of coercion at all, illegal.”

“I would completely understand and would consider accepting early use of a vaccine only if done with fully informed consent and, even then, only if offered to the most vulnerable in our community. Other proposals have, to me, the whiff of evil about them and I will oppose them as vigorously as I have followed the pandemic so far,” he concluded.

 

%d bloggers like this: